American Journal of Cancer Prevention
ISSN (Print): 2328-7314 ISSN (Online): 2328-7322 Website: Editor-in-chief: Nabil Abdel-Hamid
Open Access
Journal Browser
American Journal of Cancer Prevention. 2015, 3(5), 84-85
DOI: 10.12691/ajcp-3-5-1
Open AccessResearch Article

Diffuse large B-Cell Non-Hodgkin's of Bronchus-associated Lymphoid Tissue (BALT) Lymphomas: Case Report

Mehrdad Payandeh1, Edris Sadeghi2, 3, , Masoud Sadeghi2, 3 and Faezeh Gholami2

1Department of Hematology and Medical Oncology, Kermanshah University of Medical Sciences, Kermanshah, Iran

2Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran

3Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran

Pub. Date: October 07, 2015
(This article belongs to the Special Issue Advances in Non-Hodgkin Lymphomas)

Cite this paper:
Mehrdad Payandeh, Edris Sadeghi, Masoud Sadeghi and Faezeh Gholami. Diffuse large B-Cell Non-Hodgkin's of Bronchus-associated Lymphoid Tissue (BALT) Lymphomas: Case Report. American Journal of Cancer Prevention. 2015; 3(5):84-85. doi: 10.12691/ajcp-3-5-1


Introduction: Bronchus-associated Lymphoid Tissue (BALT) lymphomas are a rare type of extranodal marginal zone lymphomas. Herein we report a rare instance, diffuse large B cell type lymphoma can present primarily in the lung. Case Report: A 57-year-old female patient was admitted to our clinic in November 2008, with complaints of shortness of breath, fever and a cough associated with the production of small amounts of phlegm. CT scan showed interstitial infiltration in between inspiratory. Pathological report revealed lymphoproliferative disorder (diffuse large B cell lymphoma) after left lung lobectomy. She was treated with six cycles of chop (cyclophosphamide + doxorubicin + vincristine + prednisolone) chemotherapy. Chest radiographs demonstrated significantly reduced in the parnshymal tissue in both lungs. Conclusion: DLBCL of BALT is very rare with nonspecific signs and symptoms. Furthermore, CHOP chemotherapy may be an effective treatment of the disease.

BALT CHOP chemotherapy DLBCL

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


Figure of 2


[1]  Arnaoutakis K, Oo TH. Bronchus-associated lymphoid tissue lymphomas. South Med J. 2009. 102 (12): 1229-33.
[2]  Lee DK, Im JG, Lee KS, Lee JS, Seo JB, Goo JM, et al. B-cell lymphoma of bronchus-associated lymphoid tissue (BALT): CT features in 10 patients. JComput Assist Tomogr.2000. 24 (1): 30-34.
[3]  Zinzani PL, Martelli M, Poletti V, Vitolo U, Gobbi PG, Chisesi T, et al. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica. 2008. 93 (9): 1364-71. Epub 2008 Jul 4.
[4]  O’Donnell PG, Jackson SA, Tung KT, Hassan B, Wilkins B, Mead GM. Radiological appearance of lymphomas arising from mucosa-associated lymphoid tissue (MALT) in the lung. Clin Radiol. 1998. 53 (4): 258-263.
[5]  Cadranel J, Wislez M and Antoine M: Primary pulmonary lymphoma. Eur Respir J.2002. 20 (3): 750-62.
[6]  Aviles A, Nambo MJ, Huerta-Guzman J, Silva L, Neri N. Rituximab in the treatment of diffuse large B-cell lymphoma primary of the lung. Hematology. 2013 Mar; 18 (2): 81-4. Epub 2013 Jan 16.